These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38607841)

  • 1. Where to locate COVID-19 mass vaccination facilities?
    Bertsimas D; Digalakis V; Jacquillat A; Li ML; Previero A
    Nav Res Logist; 2022 Mar; 69(2):179-200. PubMed ID: 38607841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing two-dose vaccine resource allocation to combat a pandemic in the context of limited supply: The case of COVID-19.
    Zhu J; Wang Q; Huang M
    Front Public Health; 2023; 11():1129183. PubMed ID: 37168073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Location Intelligence to Evaluate the COVID-19 Vaccination Campaign in the United States: Spatiotemporal Big Data Analysis.
    Li Q; Peng JC; Mohan D; Lake B; Euler AR; Weir B; Kan L; Yang C; Labrique A
    JMIR Public Health Surveill; 2023 Feb; 9():e39166. PubMed ID: 36626835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing Spatio-Temporal Allocation of the COVID-19 Vaccine Under Different Epidemiological Landscapes.
    Cao W; Zhu J; Wang X; Tong X; Tian Y; Dai H; Ma Z
    Front Public Health; 2022; 10():921855. PubMed ID: 35812517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new vaccine supply chain network under COVID-19 conditions considering system dynamic: Artificial intelligence algorithms.
    Kamran MA; Kia R; Goodarzian F; Ghasemi P
    Socioecon Plann Sci; 2023 Feb; 85():101378. PubMed ID: 35966449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the dynamics and impact of COVID-19 vaccination on disease spread: A data-driven approach.
    Waseel F; Streftaris G; Rudrusamy B; Dass SC
    Infect Dis Model; 2024 Jun; 9(2):527-556. PubMed ID: 38525308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Initial Relationship Between the United States Department of Health and Human Services' Digital COVID-19 Public Education Campaign and Vaccine Uptake: Campaign Effectiveness Evaluation.
    Williams CJ; Kranzler EC; Luchman JN; Denison B; Fischer S; Wonder T; Ostby R; Vines M; Weinberg J; Petrun Sayers EL; Kurti AN; Trigger S; Hoffman L; Peck JFA
    J Med Internet Res; 2023 May; 25():e43873. PubMed ID: 36939670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Returning to a Normal Life via COVID-19 Vaccines in the United States: A Large-scale Agent-Based Simulation Study.
    Li J; Giabbanelli P
    JMIR Med Inform; 2021 Apr; 9(4):e27419. PubMed ID: 33872188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fair-split distribution of multi-dose vaccines with prioritized age groups and dynamic demand: The case study of COVID-19.
    Vahdani B; Mohammadi M; Thevenin S; Gendreau M; Dolgui A; Meyer P
    Eur J Oper Res; 2023 Nov; 310(3):1249-1272. PubMed ID: 37284206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing vaccine distribution via mobile clinics: a case study on COVID-19 vaccine distribution to long-term care facilities.
    Shukla S; Fressin F; Un M; Coetzer H; Chaguturu SK
    Vaccine; 2022 Jan; 40(5):734-741. PubMed ID: 35027228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparities in distribution of COVID-19 vaccines across US counties: A geographic information system-based cross-sectional study.
    Hernandez I; Dickson S; Tang S; Gabriel N; Berenbrok LA; Guo J
    PLoS Med; 2022 Jul; 19(7):e1004069. PubMed ID: 35901171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing global COVID-19 vaccine allocation: An agent-based computational model of 148 countries.
    Li Q; Huang Y
    PLoS Comput Biol; 2022 Sep; 18(9):e1010463. PubMed ID: 36067157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19: The Vaccine Race Continues.
    Burgess LH; Castelein C; Rubio A; Cooper MK
    HCA Healthc J Med; 2021; 2(2):81-91. PubMed ID: 37425646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A robust optimization problem for drone-based equitable pandemic vaccine distribution with uncertain supply.
    Wang X; Jiang R; Qi M
    Omega; 2023 Sep; 119():102872. PubMed ID: 37020741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Offering onsite COVID-19 vaccination to high-risk obstetrical patients: initial findings.
    Hirshberg JS; Huysman BC; Oakes MC; Cater EB; Odibo AO; Raghuraman N; Kelly JC
    Am J Obstet Gynecol MFM; 2021 Nov; 3(6):100478. PubMed ID: 34481996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Information From Same-Race/Ethnicity Experts Online Does Not Increase Vaccine Interest or Intention to Vaccinate.
    Gadarian SK; Goodman SW; Michener J; Nyhan B; Pepinsky TB
    Milbank Q; 2022 Jun; 100(2):492-503. PubMed ID: 35315950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An agent-based model to assess large-scale COVID-19 vaccination campaigns for the Italian territory: The case study of Lombardy region.
    Cattaneo A; Vitali A; Mazzoleni M; Previdi F
    Comput Methods Programs Biomed; 2022 Sep; 224():107029. PubMed ID: 35908330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
    Yang W; Shaman J
    medRxiv; 2021 Nov; ():. PubMed ID: 34845460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing COVID-19 vaccine allocation considering the target population.
    Wen Z; Yue T; Chen W; Jiang G; Hu B
    Front Public Health; 2022; 10():1015133. PubMed ID: 36684954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.